Respiratory Infections News

The risk for multisystem inflammatory syndrome in children, or MIS-C, is reduced to just one in a million when a person receives at least one dose of COVID-19 vaccine, researchers reported in The Lancet Child & Adolescent Health.

Moderna announced Tuesday that it has initiated a phase 3 study of its investigational messenger RNA-based vaccine for RSV.

Health care workers with a nasopharyngeal swab positive for SARS-CoV-2 were more likely to report long COVID symptoms after 6 months than negative controls in a study conducted in more than 20 Swiss hospitals.

Researchers evaluated the immune responses of a few dozen people who received three doses of a COVID-19 messenger RNA vaccine and found, as other have, that a booster shot can protect people infected with a variant from becoming very ill.

Veterans who survived COVID-19 were at increased risk for mental health, substance use and sleep disorders up to 1 year later, data showed.

In its latest public campaign to encourage parents to vaccinate their children, the AAP launched a new series of videos that address common questions parents have about childhood vaccines.

A 500 mg intramuscular injection of sotrovimab was noninferior to an IV infusion of the investigational monoclonal antibody for the treatment of mild to moderate COVID-19 in a phase 3 trial, investigators reported.

COVID-19 hospitalization rates among children aged 0 to 4 years in the U.S. were around five times higher during the peak of the omicron wave compared with the peak of the delta wave, researchers reported in MMWR.

Counties in the United States with the highest number of primary care physicians also had the highest COVID-19 vaccination rates, a cross-sectional study showed.

CDC Director Rochelle P. Walenksy, MD, MPH, had some advice for combating vaccine hesitancy in the United States.